⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34801 | 0.93 | — | — | |
| SCHEMBL6754664 | 0.86 | — | — | |
| Water SCHEMBL28143155 | 0.86 | — | — | |
| SCHEMBL8610296 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL27868053 | 0.86 | — | — | |
| SCHEMBL990627 | 0.86 | — | — | |
| SCHEMBL10172352 | 0.77 | — | — | |
| Benzene SCHEMBL27719523 | 0.76 | TSHR (0.33) | — | |
| Trimethylammonium SCHEMBL11615551 | 0.68 | — | — | |
| SCHEMBL21609889 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5912352-A | CATALYTIC REDUCTION OF HYDRAZIDE TO HYDRAZINE DERIVATIVE IN PRESENCE OF COMPLEX HYDRIDE; ACYL MIGRATION; HYDROGENATION; CATALYST SELECTIVITY | NOVARTIS FINANCE CORPORATION (US) | 1999-06-15 | — | — | US | claimed |
| WO-1997046514-A1 | PROCESS FOR THE PREPARATION OF HYDRAZINE DERIVATIVES USEFUL AS INTERMEDIATES FOR THE PREPARATION OF PEPTIDE ANALOGUES | NOVARTIS AG (CH) | 1997-12-11 | — | — | WO | claimed |
| CN-112895361-A | Oxyhydrogen atomizer casing injection mold | 上海利劲塑胶模具有限公司 | 2021-06-04 | — | — | CN | disclosed |
| EP-3065743-B1 | PRODUCTION OF 6-HYDROXY MORPHINANS WITHOUT THE ISOLATION OF INTERMEDIATES | SpecGx LLC (US) | 2019-05-29 | — | — | EP | disclosed |
| EP-3065743-A1 | PRODUCTION OF 6-HYDROXY MORPHINANS WITHOUT THE ISOLATION OF INTERMEDIATES | Mallinckrodt LLC (US) | 2016-09-14 | — | — | EP | disclosed |
| US-9193737-B2 | Production of 6-hydroxy morphinans without the isolation of intermediates | MALLINCKRODT LLC (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2015069717-A1 | PRODUCTION OF 6-HYDROXY MORPHINANS WITHOUT THE ISOLATION OF INTERMEDIATES | MALLINCKRODT LLC (US) | 2015-05-14 | — | — | WO | disclosed |
| US-20150126742-A1 | PRODUCTION OF 6-HYDROXY MORPHINANS WITHOUT THE ISOLATION OF INTERMEDIATES | OCERA THERAPEUTICS LLC | 2015-05-07 | — | — | US | disclosed |
| US-20080052904-A1 | Method Of Manufacturing An Electronic Circuit Assembly | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-03-06 | — | — | US | disclosed |
| WO-2006010639-A2 | METHOD OF MANUFACTURING AN ELECTRONIC CIRCUIT DEVICE THROUGH A DIRECT WRITE TECHNIQUE | ATOTECH DEUTSCHLAND GMBH (DE) | 2006-02-02 | — | — | WO | disclosed |
| EP-1622435-A1 | Method of manufacturing an electronic circuit assembly using direct write techniques | ATOTECH Deutschland GmbH (DE) | 2006-02-01 | — | — | EP | disclosed |
| EP-0876336-B1 | AZAHEXANE DERIVATIVES AS SUBSTRATE ISOSTERS OF RETROVIRAL ASPARATE PROTEASES | NOVARTIS AG (CH) | 2002-06-05 | — | — | EP | disclosed |
| US-6225345-B1 | FOR THERAPY OF ACQUIRED IMMUNODEFICIENCY SYNDROME | NOVARTIS AG (CH) | 2001-05-01 | — | — | US | disclosed |
| US-5912352-A | CATALYTIC REDUCTION OF HYDRAZIDE TO HYDRAZINE DERIVATIVE IN PRESENCE OF COMPLEX HYDRIDE; ACYL MIGRATION; HYDROGENATION; CATALYST SELECTIVITY | NOVARTIS FINANCE CORPORATION (US) | 1999-06-15 | — | — | US | disclosed |
| EP-0876336-A1 | AZAHEXANE DERIVATIVES AS SUBSTRATE ISOSTERS OF RETROVIRAL ASPARATE PROTEASES | Novartis AG (CH) | 1998-11-11 | — | — | EP | disclosed |
| US-5808070-A | Process for preparing alkaline aminoborohydrides and alkaline aminoborohydride complexes | METALLGESELLSCHAFT AKTIENGESELLSCHAFT (DE) | 1998-09-15 | — | — | US | disclosed |
| WO-1997046514-A1 | PROCESS FOR THE PREPARATION OF HYDRAZINE DERIVATIVES USEFUL AS INTERMEDIATES FOR THE PREPARATION OF PEPTIDE ANALOGUES | NOVARTIS AG (CH) | 1997-12-11 | — | — | WO | disclosed |
| WO-1997019055-A1 | AZAHEXANE DERIVATIVES AS SUBSTRATE ISOSTERS OF RETROVIRAL ASPARATE PROTEASES | NOVARTIS AG (CH) | 1997-05-29 | — | — | WO | disclosed |
| US-5466798-A | Reducing agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-11-14 | — | — | US | disclosed |